المؤلفون: Brunen, D, Garcia-Barchino, MJ, Malani, D, Basheer, NJ, Lieftink, C, Beijersbergen, RL, Murumagi, A, Porkka, K, Wolf, M, Zwaan, CM, Fornerod, M, Kallioniemi, O, Martinez-Climent, JA, Bernards, R

المصدر: Oncotarget. 7(25):37407-37419

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:133795202

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Larrayoz M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Garcia-Barchino MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Celay J; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Etxebeste A; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Jimenez M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Perez C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Ordoñez R; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Cobaleda C; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Botta C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Fresquet V; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Roa S; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Goicoechea I; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Maia C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Lasaga M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Chesi M; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA., Bergsagel PL; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA., Larrayoz MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Calasanz MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Campos-Sanchez E; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Martinez-Cano J; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Panizo C; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Rodriguez-Otero P; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Vicent S; Program in Solid Tumors, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Roncador G; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain., Gonzalez P; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain., Takahashi S; Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Katz SG; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Walensky LD; Department of Pediatric Oncology and Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ruppert SM; Oncology Biomarker Development, Genentech, South San Francisco, CA, USA., Lasater EA; Department of Translational Oncology, Genentech, South San Francisco, CA, USA., Amann M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland., Lozano T; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Llopiz D; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Sarobe P; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Lasarte JJ; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Planell N; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain., Gomez-Cabrero D; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain.; Biological and Environmental Sciences & Engineering Division, King Abdullah University of Science & Technology, Thuwal, Kingdom of Saudi Arabia., Kudryashova O; BostonGene, Waltham, MA, USA., Kurilovich A; BostonGene, Waltham, MA, USA., Revuelta MV; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Cerchietti L; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Agirre X; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., San Miguel J; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Paiva B; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Prosper F; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Martinez-Climent JA; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain. jamcliment@unav.es.

المصدر: Nature medicine [Nat Med] 2023 Mar; Vol. 29 (3), pp. 632-645. Date of Electronic Publication: 2023 Mar 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy, Mice ; Animals ; CD8-Positive T-Lymphocytes ; Immune Evasion ; T-Lymphocytes, Regulatory ; Immunotherapy/adverse effects ; Tumor Microenvironment/genetics

المؤلفون: Rodriguez S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Celay J; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Goicoechea I; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Jimenez C; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain., Botta C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Garcia-Barchino MJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Garces JJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Larrayoz M; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Santos S; Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal., Alignani D; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Vilas-Zornoza A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Perez C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Garate S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Sarvide S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Lopez A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, DKTK Partner Site Essen, Center for Molecular Biotechnology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany., Carrasco YR; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain., Sanchez-Garcia I; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Larrayoz MJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Calasanz MJ; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Panizo C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Prosper F; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Lamo-Espinosa JM; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Motta M; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Tucci A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Sacco A; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Gentile M; Department of Oncohematology, 'Annunziata' Hospital, Cosenza, Italy., Duarte S; Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal., Vitoria H; Hospital de S. Teotónio, Viseu, Portugal., Geraldes C; Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal., Paiva A; Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal., Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain., Garcia-Sanz R; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain., Roccaro AM; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Fuerte G; Mission Bio, San Francisco, CA, USA., San Miguel JF; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Martinez-Climent JA; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain., Paiva B; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

المصدر: Science advances [Sci Adv] 2022 Jan 21; Vol. 8 (3), pp. eabl4644. Date of Electronic Publication: 2022 Jan 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma* , Lymphoma, B-Cell*/metabolism , Waldenstrom Macroglobulinemia*/diagnosis , Waldenstrom Macroglobulinemia*/genetics , Waldenstrom Macroglobulinemia*/pathology, Aged ; Animals ; Humans ; Mice ; Mutation ; Myeloid Differentiation Factor 88/genetics ; Myeloid Differentiation Factor 88/metabolism

المؤلفون: Fresquet V; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain. jamcliment@unav.es vfresquet@unav.es., Garcia-Barchino MJ; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Larrayoz M; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Celay J; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Vicente C; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Fernandez-Galilea M; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain.; Center for Nutrition Research and Department of Nutrition, Food Science and Physiology, University of Navarra, IDISNA, CIBEROBN, Pamplona, Spain., Larrayoz MJ; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Calasanz MJ; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Panizo C; Department of Hematology, Clinica Universidad de Navarra, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Junza A; Universitat Rovira i Virgili, Department of Electronic Engineering, IISPV, CIBERDEM, Tarragona, Spain., Han J; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China., Prior C; Division of Gene Therapy and Hepatology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Fortes P; Division of Gene Therapy and Hepatology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Pio R; Division of Solid Tumors, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Oyarzabal J; Division of Molecular Therapeutics, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, Pamplona, Spain., Martinez-Baztan A; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Paiva B; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Moreno-Aliaga MJ; Center for Nutrition Research and Department of Nutrition, Food Science and Physiology, University of Navarra, IDISNA, CIBEROBN, Pamplona, Spain., Odero MD; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Agirre X; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Yanes O; Universitat Rovira i Virgili, Department of Electronic Engineering, IISPV, CIBERDEM, Tarragona, Spain., Prosper F; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Martinez-Climent JA; Division of Hematology, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain. jamcliment@unav.es vfresquet@unav.es.

المصدر: Cancer discovery [Cancer Discov] 2021 May; Vol. 11 (5), pp. 1268-1285. Date of Electronic Publication: 2020 Dec 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Epigenesis, Genetic/*drug effects , Mitochondria/*drug effects , Neoplasms/*drug therapy, Apoptosis/drug effects ; Cell Line, Tumor ; Humans

المؤلفون: Pascual M; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Mena-Varas M; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Robles EF; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Garcia-Barchino MJ; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Panizo C; Department of Hematology, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, University of Navarra, Pamplona, Spain., Hervas-Stubbs S; Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, University of Navarra, Pamplona, Spain., Alignani D; Cytometry Unit, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Sagardoy A; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Martinez-Ferrandis JI; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Bunting KL; New York Genome Center, New York, NY.; Department of Medicine/Hematology-Oncology, Weill Cornell Medical College, New York, NY., Meier S; Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook , NY., Sagaert X; Centre for Translation Cell and Tissue Research, KU Leuven, Leuven, Belgium., Bagnara D; Karches Center for Oncology Research, Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY.; Department of Experimental Medicine, University of Genoa, Genoa, Italy., Guruceaga E; Bioinformatics Platform, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, ProteoRed-ISCIII, University of Navarra, Pamplona, Spain; and., Blanco O; Department of Pathology, University of Salamanca, Salamanca, Spain., Celay J; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Martínez-Baztan A; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Casares N; Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, University of Navarra, Pamplona, Spain., Lasarte JJ; Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, University of Navarra, Pamplona, Spain., MacCarthy T; Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook , NY., Melnick A; Department of Medicine/Hematology-Oncology, Weill Cornell Medical College, New York, NY., Martinez-Climent JA; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain., Roa S; Hemato-Oncology Program, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBERONC, University of Navarra, Pamplona, Spain.

المصدر: Blood [Blood] 2019 May 30; Vol. 133 (22), pp. 2401-2412. Date of Electronic Publication: 2019 Apr 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic* , Lymphocyte Activation* , Tumor Escape*, B-Lymphocytes/*immunology , B7-H1 Antigen/*immunology , Lymphoma, Large B-Cell, Diffuse/*immunology , Programmed Cell Death 1 Receptor/*immunology , Tumor Suppressor Protein p53/*immunology, Animals ; B-Lymphocytes/pathology ; B7-H1 Antigen/genetics ; Female ; Humans ; Immunotherapy ; Lymphoma, Large B-Cell, Diffuse/genetics ; Lymphoma, Large B-Cell, Diffuse/pathology ; Lymphoma, Large B-Cell, Diffuse/therapy ; Male ; Mice ; Mice, Transgenic ; Programmed Cell Death 1 Receptor/genetics ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Tumor Suppressor Protein p53/genetics

المؤلفون: Arendt LM; Department of Comparative Biosciences, University of Wisconsin-Madison, 2015 Linden Dr., Madison, WI 53706, USA., Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2011 Jan 28; Vol. 13 (1), pp. R11. Date of Electronic Publication: 2011 Jan 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*metabolism , Carcinoma/*metabolism , Estrogens/*physiology , Mammary Neoplasms, Experimental/*metabolism , Prolactin/*genetics, Animals ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics ; Carcinoma/genetics ; Cluster Analysis ; Disease Models, Animal ; Epithelial Cells/metabolism ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Female ; Gene Expression Profiling ; Humans ; Male ; Mammary Neoplasms, Experimental/etiology ; Mammary Neoplasms, Experimental/genetics ; Mice ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Transgenic ; Prolactin/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; STAT5 Transcription Factor/metabolism ; Transcription Factor AP-1/metabolism

المؤلفون: Arendt LM; Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA., Evans LC, Rugowski DE, Garcia-Barchino MJ, Rui H, Schuler LA

المصدر: The Journal of endocrinology [J Endocrinol] 2009 Oct; Vol. 203 (1), pp. 99-110. Date of Electronic Publication: 2009 Jul 27.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BioScientifica Country of Publication: England NLM ID: 0375363 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-6805 (Electronic) Linking ISSN: 00220795 NLM ISO Abbreviation: J Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Aging/*metabolism , Estrogens/*metabolism , Mammary Neoplasms, Experimental/*metabolism , Precancerous Conditions/*metabolism , Prolactin/*metabolism, Animals ; Cell Proliferation ; Estradiol ; Estrogen Receptor alpha/metabolism ; Female ; Gene Expression ; Mammary Glands, Animal/physiology ; Mice ; Mice, Transgenic ; Neoplastic Processes ; Signal Transduction